Valneva SE - American Depositary Shares – Quartalsbilanz (NASDAQ:VALN) | MetaTrader

Vollständige Grafik anzeigen

Valneva SE - American Depositary Shares

Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.

Nachrichten

VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study

Jefferies bestätigt Kaufempfehlung für Valneva nach Daten zur Lyme-Borreliose-Impfung

Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Anghami (NASDAQ:ANGH), CF Industries Holdings (NYSE:CF)

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Borreliose-Impfstoff von Pfizer und Valneva erreicht 73 % Wirksamkeit in Studie

Valneva übertrifft im 4. Quartal 2025 die Gewinnerwartungen, Aktie legt zu

Valneva SE: EPS übertrifft Schätzungen um 0,13 $ - Umsatz besser als erwartet

Valneva SE earnings beat by $0.13, revenue topped estimates

Valneva Steps Back From US Approval Bid For Chikungunya Vaccine - Valneva (NASDAQ:VALN)

Valneva-Aktie fällt nach Rückzug des Zulassungsantrags für Chikungunya-Impfstoff in den USA

Valneva stock falls after withdrawing chikungunya vaccine BLA in U.S.

Valneva, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Aeva Technologies (NASDAQ:AEVA), ALT5 Sigma (NASDAQ:ALTS)